ミネソタ州における結腸癌の臨床試験
ミネソタ州内の拠点で、結腸癌に関する18件の研究が参加者を募集しています。
ミネソタ州内の都市
- Rochester9件の研究
- Minneapolis7件の研究
- Duluth6件の研究
- Plymouth5件の研究
- Saint Paul4件の研究
- Brooklyn Park4件の研究
- Bloomington4件の研究
公式研究テキスト（英語）
Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays
- Riverwood Healthcare Center, Aitkin
- Essentia Health - Baxter Clinic, Baxter
- Sanford Joe Lueken Cancer Center, Bemidji
- 他44件
被験者募集中健康なボランティア歓迎
18歳以上 · 全性別 · 2026/10/02更新 · NCT07283939Family Communications After Genetic Testing
- Riverwood Healthcare Center, Aitkin
- Essentia Health - Baxter Clinic, Baxter
- Essentia Health Saint Joseph's Medical Center, Brainerd
- 他41件
被験者募集中健康なボランティア歓迎
18歳以上 · 全性別 · 2026/10/02更新 · NCT07143487A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)
- Mayo Clinic in Rochester, Minnesota ( Site 0091), Rochester
被験者募集中第3相
18歳以上 · 全性別 · 2026/10/01更新 · NCT06997497PRE-ISPY Phase I/II Oncology Platform Program
- University of Minnesota Masonic Cancer Center, Minneapolis
- Mayo Clinic Comprehensive Cancer Center, Rochester
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/30更新 · NCT05868226Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
- Avera Cancer Institute- Marshall, Marshall
- Mayo Clinic Hospital, Methodist Campus, Research Pharmacy, Rochester
- Mayo Clinic Pharmacy, Rochester
- 他4件
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/28更新 · NCT07222800ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
- Mayo Clinic (Rochester), Rochester
被験者募集中観察研究
18歳以上 · 全性別 · 2026/09/14更新 · NCT05059444Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
- Riverwood Healthcare Center, Aitkin
- Essentia Health - Baxter Clinic, Baxter
- Sanford Joe Lueken Cancer Center, Bemidji
- 他46件
被験者募集中
45歳〜70歳 · 全性別 · 2026/09/02更新 · NCT05080673Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
- Sanford Joe Lueken Cancer Center, Bemidji
- Essentia Health Saint Joseph's Medical Center, Brainerd
- Minnesota Oncology - Burnsville, Burnsville
- 他34件
被験者募集中第2/3相
18歳以上 · 全性別 · 2026/09/02更新 · NCT05174169Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma
- Xencor Investigative Site, Rochester
被験者募集中第1相
18歳以上 · 全性別 · 2026/08/03更新 · NCT05433142Integrated Cancer Repository for Cancer Research
- Riverwood Healthcare Center, Aitkin
- Essentia Health-St. Joseph's Medical Center, Brainerd
- Essentia Health - Duluth Clinic, Duluth
- 他2件
被験者募集中観察研究健康なボランティア歓迎
19歳〜110歳 · 全性別 · 2026/06/29更新 · NCT02012699A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
- Mayo Clinic Rochester, Rochester
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/06/12更新 · NCT06051695A Study of Fruquintinib Plus FOLFIRI as Second-Line Treatment for Participants With Metastatic Colorectal Cancer (FRUITFUL)
- Minnesota Oncology Hematology - Primary, Maple Grove
被験者募集中第2相
18歳以上 · 全性別 · 2026/06/12更新 · NCT07011576The Sarah Nanotechnology System for Treatment of Advanced Metastatic Solid Tumors Using Hyperthermia.
- Mayo Clinic, Rochester
被験者募集中
18歳以上 · 全性別 · 2026/05/15更新 · NCT07224464Evaluation of Stool Based Markers for the Early Detection of Colorectal Cancers and Adenomas
- University of Minnesota, Minneapolis
被験者募集中観察研究
18歳以上 · 全性別 · 2026/05/11更新 · NCT00843375Avera Cancer Sequencing and Analytics Protocol (ASAP)
- Avera Cancer Institute - Marshall, Marshall
被験者募集中観察研究
18歳以上 · 全性別 · 2026/03/27更新 · NCT05142033Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer
- GSK Investigational Site, Minneapolis
被験者募集中第3相
18歳以上 · 全性別 · 2026/01/23更新 · NCT05855200SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Duluth
被験者募集中観察研究
全年齢 · 全性別 · 2025/10/28更新 · NCT03452774A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
- Mayo Clinic, Rochester
被験者募集中第1/2相
18歳以上 · 全性別 · 2025/09/09更新 · NCT06682793ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。